Nausea, vomiting, diarrhea, and abdominal pain are some of the more common side effects of weight-loss medications (for a full list of side effects, visit the drug manufacturers website)
They determined that those prescribed GLP-1 agonists exhibit a significantly lower risk of developing RVO over five years, particularly for branch RVO (BRVO), compared to those on DPP-4 inhibitors, which could contribute to favorable long-term ocular outcomes and reduce the burden of visual impairment with this treatment option in this population
Bajaj S, Mahajan A, Grover S, Mahajan V, Goyal P, Gupta VK (2017) Peripheral vascular disease in patients with diabetic foot ulcers an emerging trend: a prospective study from North India
Poison-control centers reported an enormous jump in semaglutide-related calls last year
YOURE BUSY
L-Carnitine LS3 supports your health journey without any unwanted additives and is Calorie-Free, Sugar-Free, Gluten-Free, & Keto-Friendly